טוען...
Molecular Pathology of Lung Cancer: Current Status and Future Directions
The rapid development of targeted therapies has enormously changed the clinical management of lung cancer patients over the past decade; therefore, molecular testing, such as epidermal growth factor receptor (EGFR) gene mutations or anaplastic lymphoma kinase (ALK) gene rearrangements, is now routin...
שמור ב:
| מחבר ראשי: | |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4165659/ https://ncbi.nlm.nih.gov/pubmed/25237374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4046/trd.2014.77.2.49 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|